Independent Advisor Alliance Reduces Stock Holdings in Axon Enterprise, Inc. (NASDAQ:AXON)

Independent Advisor Alliance cut its holdings in Axon Enterprise, Inc. (NASDAQ:AXON) by 1.9% during the 3rd quarter, Holdings Channel.com reports. The institutional investor owned 2,509 shares of the biotechnology company’s stock after selling 48 shares during the quarter. Independent Advisor Alliance’s holdings in Axon Enterprise were worth $1,003,000 at the end of the most recent reporting period.

A number of other large investors have also recently added to or reduced their stakes in AXON. B. Riley Wealth Advisors Inc. lifted its holdings in shares of Axon Enterprise by 24.4% in the first quarter. B. Riley Wealth Advisors Inc. now owns 6,266 shares of the biotechnology company’s stock valued at $1,961,000 after purchasing an additional 1,229 shares in the last quarter. California State Teachers Retirement System raised its position in shares of Axon Enterprise by 1.4% during the 1st quarter. California State Teachers Retirement System now owns 116,206 shares of the biotechnology company’s stock worth $36,359,000 after purchasing an additional 1,603 shares during the last quarter. Tidal Investments LLC lifted its stake in Axon Enterprise by 22.4% in the 1st quarter. Tidal Investments LLC now owns 4,833 shares of the biotechnology company’s stock valued at $1,512,000 after buying an additional 884 shares in the last quarter. LBP AM SA acquired a new stake in Axon Enterprise during the 1st quarter valued at $1,041,000. Finally, Virtu Financial LLC increased its position in Axon Enterprise by 151.8% during the first quarter. Virtu Financial LLC now owns 4,283 shares of the biotechnology company’s stock worth $1,340,000 after buying an additional 2,582 shares in the last quarter. 79.08% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several analysts have recently issued reports on AXON shares. Needham & Company LLC upped their price objective on Axon Enterprise from $525.00 to $600.00 and gave the company a “buy” rating in a research report on Friday, November 8th. JMP Securities raised their price target on shares of Axon Enterprise from $430.00 to $500.00 and gave the stock a “market outperform” rating in a research note on Thursday, October 31st. Barclays boosted their price objective on shares of Axon Enterprise from $381.00 to $387.00 and gave the company an “overweight” rating in a research report on Wednesday, August 7th. The Goldman Sachs Group raised their target price on shares of Axon Enterprise from $385.00 to $441.00 and gave the stock a “buy” rating in a research report on Wednesday, October 23rd. Finally, Craig Hallum lifted their target price on shares of Axon Enterprise from $370.00 to $376.00 and gave the stock a “buy” rating in a research note on Wednesday, August 7th. Two equities research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. According to MarketBeat, Axon Enterprise currently has a consensus rating of “Moderate Buy” and an average price target of $427.83.

Insiders Place Their Bets

In related news, Director Julie A. Cullivan sold 900 shares of Axon Enterprise stock in a transaction on Thursday, September 5th. The shares were sold at an average price of $353.53, for a total transaction of $318,177.00. Following the transaction, the director now owns 3,653 shares in the company, valued at approximately $1,291,445.09. The trade was a 19.77 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CFO Brittany Bagley sold 4,338 shares of the company’s stock in a transaction on Thursday, September 12th. The stock was sold at an average price of $378.95, for a total transaction of $1,643,885.10. Following the sale, the chief financial officer now directly owns 98,825 shares of the company’s stock, valued at approximately $37,449,733.75. This trade represents a 4.20 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 260,256 shares of company stock worth $105,984,120 over the last three months. 5.70% of the stock is owned by insiders.

Axon Enterprise Trading Up 2.1 %

Shares of AXON opened at $632.16 on Wednesday. Axon Enterprise, Inc. has a twelve month low of $224.28 and a twelve month high of $641.20. The firm has a market capitalization of $48.20 billion, a P/E ratio of 163.35, a price-to-earnings-growth ratio of 13.62 and a beta of 0.94. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. The stock’s fifty day simple moving average is $468.24 and its 200 day simple moving average is $370.65.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.